BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 26, 2004
View Archived Issues
R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Ecopia
Read More
Novel 5-HT1F agonists with improved bioavailability for migraine therapy
Read More
R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Generex
Read More
M-826 is neuroprotective in a rat malonate model of Huntington's disease
Read More
WIN-55212-2 decreases hyperalgesia and pronociceptive mediators in a rat model of neuropathic pain
Read More
Topical resveratrol inhibits cutaneous HSV lesion formation in hairless mice
Read More
R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Genopia
Read More
R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Hudson Health
Read More
GABA-A alpha5 receptor inverse agonists with potential as cognition-enhancing agents
Read More
Novel HCV polymerase inhibitors for chronic hepatitis C therapy
Read More
Effects of hepatic and renal impairment on the pharmacokinetics of telbivudine
Read More
Chiron patent covers bacterial meningitis vaccines
Read More
LB-80380 reported to reduce serum HBV DNA levels in hepatitis B patients
Read More
Two series of DHFR inhibitors/melanocortin receptor modulators for IBD and other uses
Read More
Good safety and pharmacokinetic profile of Albuferon-alpha in chronic hepatitis C patients
Read More
New dopamine D1/D5 antagonists with potential in obesity and CNS disorders
Read More
Novel post-Amadori AGE inhibitors prepared and tested at BioStratum
Read More
Entecavir reduces viral levels in HBV-infected patients unresponsive to lamivudine
Read More
New alpha7 nAChR agonists claimed by Memory Pharmaceuticals researchers
Read More
Phase II trial of INS-37217 Ophthalmic for rhegmatogenous retinal detachment
Read More
Phenoxodiol studied in new ovarian cancer trial
Read More
Dose ranging study for EP-1572 growth hormone secretagogue
Read More
Interim data from phase II clofarabine study in AML reveal complete responses
Read More
Japanese approval sought for Peg-Intron plus Rebetol for chronic hepatitis C
Read More
Apokyn approved for off episodes associated with Parkinson's
Read More
IND clearance for squalamine in neovascular diseases of the eye
Read More
Approvable letter for Concerta
Read More
SBIR grant supports efforts at Adenosine Therapeutics in type 2 diabetes
Read More
Enrollment under way in phase II trial of avanafil for erectile dysfunction
Read More
Improved efficacy reported for ezetimibe/simvastatin in adult patients with hypercholesterolemia
Read More
Health Canada clears multiple dose range finding study for trans-ISA-247
Read More
Aventis Boards recommend improved offer from Sanofi-Synthelabo to create Sanofi-Aventis
Read More